Charcoal Burner

Russula cyanoxantha

Evidence Rating

E Limited

Confidence Level

Low

Traditions

Western

Part Used

Fruiting body (fresh or dried basidiocarp)

Last Updated

2/25/2026

Summary

Russula cyanoxantha (Charcoal Burner) is one of Europe's most esteemed wild edible mushrooms, distinguished by its exceptional texture and flavor profile. Nutritional analyses reveal a rich profile of phenolic antioxidants (gallic acid, p-hydroxybenzoic acid), tocopherols (vitamin E compounds), organic acids, and a favorable protein and mineral composition. In vitro studies demonstrate significant free radical scavenging and metal chelation capacity. While it lacks any formal pharmacological tradition or clinical evidence, its well-characterized antioxidant nutritional profile positions it as a functional food of interest for dietary antioxidant intake. As an obligate ectomycorrhizal species with broadleaf trees, it cannot be cultivated and is available only through wild harvest.

Key Bioactive Compounds

Phenolic compounds (gallic acid, p-hydroxybenzoic acid) Tocopherols (alpha-tocopherol, gamma-tocopherol) Organic acids (malic acid, oxalic acid, fumaric acid) Polysaccharides Ergosterol (provitamin D2) Ascorbic acid

Regulatory Status

Regulatory Body Status
FDA GRAS (USA) —
EU Novel Food —
Chinese Pharmacopoeia —
Japanese Pharmaceutical —

Metadata

FieldDetail
Common NamesCharcoal Burner, Blue-and-Yellow Russula, Charbonniere (French), Frauentaubling (German), Colombina maggiore (Italian)
Scientific NameRussula cyanoxantha (Schaeff.) Fr.
Fungal FamilyRussulaceae (Basidiomycota, order Russulales)
Part UsedFruiting body (basidiocarp); consumed fresh or dried; no traditional extract preparations
Primary BioactivesPhenolic compounds (gallic acid, p-hydroxybenzoic acid, protocatechuic acid), tocopherols (alpha-tocopherol, gamma-tocopherol), organic acids (malic acid, oxalic acid, fumaric acid, citric acid), ascorbic acid, polysaccharides, ergosterol
HabitatEctomycorrhizal with broadleaf trees, especially beech (Fagus), oak (Quercus), and birch (Betula); widespread in temperate European and North American forests; fruits June through November in deciduous and mixed woodland
Culinary StatusRegarded as one of the finest edible Russula species; distinctive non-brittle gill structure (unique within the genus); excellent texture and mild, nutty flavor; highly prized in French, Italian, and German cuisine
CultivationCannot be cultivated. As an obligate ectomycorrhizal species, it requires a living tree host for nutrition and cannot be grown on artificial substrates. Available only through wild harvest
Evidence RatingE (Limited) — Nutritional and food chemistry data well-characterized; in vitro antioxidant activity demonstrated; no pharmacological tradition; no clinical trials; medicinal potential inferred from nutritional composition

Regulatory Status

European Union

  • Food status: Russula cyanoxantha is a recognized edible wild mushroom traded in European markets, particularly in France, Italy, Germany, and Eastern Europe. It is sold fresh in local markets during the mushroom season (late summer-autumn). No novel food authorization is required for the whole fruiting body, as it has a long history of consumption as food in the EU.
  • Foraging regulations: Wild harvest regulations vary by country and region. In many European countries, quantity limits apply to personal collection, and commercial harvesting may require permits.
  • No EMA/HMPC monograph — not recognized as a medicinal product.

United States

  • Food status: Wild-collected R. cyanoxantha is consumed by foragers but is not commercially available in most US markets. Not a commonly recognized species in North American foraging culture compared to European traditions.
  • FDA status: Not evaluated as a drug or dietary supplement.

France

  • Culinary tradition: Known as “Charbonniere” or “Russule charbonniere,” it is one of the most sought-after wild mushrooms in French cuisine. Widely collected for personal use and sold in regional markets. Included in French mycological field guides as an “excellent edible.”

Italy

  • Culinary tradition: “Colombina maggiore” is a valued market mushroom in Italian regional cuisine. Wild-collected specimens are sold in local markets, particularly in northern and central Italy.

No Pharmacopoeial Recognition

  • Not listed in any pharmacopoeia worldwide. No traditional medicinal use has been formally documented in any pharmacological tradition. Its relevance to this reference is based on nutritional composition and in vitro antioxidant data.

Conditions & Indications

Primary: Antioxidant Nutrition (Food Chemistry Evidence)

  • Dietary antioxidant source: R. cyanoxantha provides a significant dietary source of phenolic antioxidants, tocopherols, and organic acids. Comparative analyses of wild European mushroom species consistently rank R. cyanoxantha among the top species for total antioxidant capacity, as measured by DPPH, reducing power, and beta-carotene/linoleate assays.
  • Phenolic antioxidants: Gallic acid, p-hydroxybenzoic acid, and protocatechuic acid are present in nutritionally meaningful concentrations. These phenolics are established dietary antioxidants with documented health benefits in the food science literature, including cardiovascular protection and anti-inflammatory effects when consumed as part of a balanced diet.
  • Tocopherol content: Alpha-tocopherol and gamma-tocopherol (vitamin E compounds) are present, contributing to the lipid-soluble antioxidant profile. Tocopherols protect cell membranes from lipid peroxidation and are essential dietary micronutrients.

Secondary: Nutritional Value (Food Composition Data)

  • Protein content: Contains 15-25% protein on a dry weight basis, with a favorable essential amino acid profile. The protein content is comparable to other high-value edible mushrooms and exceeds that of many vegetables.
  • Mineral content: Good source of potassium, phosphorus, magnesium, and zinc. Iron content is moderate. The mineral profile supports cardiovascular and metabolic health when the mushroom is consumed as a regular dietary component.
  • Low caloric density: High water content (85-92% fresh weight) with low fat and calorie content, characteristic of edible mushrooms. Suitable for weight management diets.
  • Dietary fiber: Contains significant dietary fiber (chitin and beta-glucans) that may contribute to digestive health and satiety.

Emerging/Preclinical

  • In vitro free radical scavenging: Multiple studies report significant DPPH radical, hydroxyl radical, and superoxide anion scavenging activity of R. cyanoxantha extracts. Some studies report EC50 values for DPPH scavenging that are competitive with ascorbic acid at equivalent concentrations.
  • Metal chelation: Extracts demonstrate Fe2+ and Cu2+ chelation capacity, which could contribute to antioxidant protection by preventing metal-catalyzed oxidative damage in biological systems.
  • Anti-lipid peroxidation: The beta-carotene/linoleate assay demonstrates inhibition of lipid peroxidation by R. cyanoxantha extracts, relevant to protection of cellular membranes and lipoproteins from oxidative degradation.
  • Polysaccharide immunomodulation: [NEEDS-RESEARCH] Preliminary evidence suggests that polysaccharide fractions from Russula species may have immunomodulatory properties, but specific data for R. cyanoxantha polysaccharides are limited.
  • Antimicrobial activity: [NEEDS-RESEARCH] Some screening studies have noted mild antimicrobial activity of R. cyanoxantha extracts, but the evidence is inconsistent and the clinical significance is unclear.

Mechanism of Action

Primary Mechanisms

  1. Phenolic antioxidant radical scavenging: The phenolic compounds in R. cyanoxantha — principally gallic acid, p-hydroxybenzoic acid, and protocatechuic acid — function as hydrogen atom donors to free radicals, converting reactive oxygen species (ROS) into stable, non-toxic products. Gallic acid (3,4,5-trihydroxybenzoic acid) is particularly effective due to its three adjacent hydroxyl groups, which provide optimal geometry for radical stabilization through resonance. The multiple phenolics present act synergistically, with overlapping radical scavenging capacities across different ROS species (superoxide, hydroxyl, peroxyl radicals).

  2. Tocopherol-mediated lipid peroxidation protection: Alpha-tocopherol and gamma-tocopherol are lipid-soluble chain-breaking antioxidants that intercept lipid peroxyl radicals within cell membranes and lipoproteins, terminating the lipid peroxidation chain reaction. This mechanism protects membrane integrity and prevents oxidative modification of LDL cholesterol (a key step in atherosclerosis). The tocopherol content of R. cyanoxantha is nutritionally meaningful but not pharmacological in concentration.

  3. Transition metal chelation: Phenolic compounds and organic acids in R. cyanoxantha chelate pro-oxidant transition metals (Fe2+ and Cu2+), preventing their participation in Fenton and Haber-Weiss reactions that generate the highly destructive hydroxyl radical. This indirect antioxidant mechanism complements direct radical scavenging by reducing the rate of ROS generation at its source.

Secondary Mechanisms

  • Organic acid metabolic contributions: Malic acid, fumaric acid, and citric acid participate in cellular energy metabolism (Krebs cycle intermediates) and contribute to the overall metabolic health profile of the mushroom as a food.
  • Ergosterol as provitamin D2: Ergosterol is converted to vitamin D2 (ergocalciferol) upon exposure to ultraviolet light. Dried or sun-exposed R. cyanoxantha specimens may contain elevated vitamin D2 levels, relevant to bone health and immune function.
  • Dietary fiber and gut health: Chitin and beta-glucan polysaccharides serve as dietary fiber, promoting gut health through prebiotic effects and contributing to satiety and glycemic control. The immunomodulatory potential of beta-glucans, while documented for other mushroom species, has not been specifically investigated for R. cyanoxantha.

Nutritional Composition (Representative Values)

NutrientConcentration (dry weight)Significance
Protein15-25%Comparable to high-value edible mushrooms
Total phenolics5-15 mg GAE/g extractSignificant antioxidant contributor
Alpha-tocopherol0.5-2.5 ug/gVitamin E activity
Gamma-tocopherol0.3-1.5 ug/gDistinct antioxidant properties from alpha-tocopherol
Ascorbic acid10-30 mg/100g fresh weightVitamin C contribution
Potassium2,500-4,000 mg/100g dry weightCardiovascular support
Phosphorus500-800 mg/100g dry weightBone and energy metabolism
ErgosterolPresent (variable)Provitamin D2 precursor
Total dietary fiber15-30% dry weightGut health, satiety

Clinical Evidence Summary

No clinical trials or formal pharmacological studies have been conducted with Russula cyanoxantha. The evidence base consists entirely of food chemistry analyses, nutritional composition studies, and in vitro antioxidant assays.

Food Chemistry and Antioxidant Studies

StudyAnalysisKey Results
Heleno et al. (2010)DPPH, reducing power, beta-carotene/linoleate assays; phenolic and tocopherol profilingR. cyanoxantha ranked among the top antioxidant species in a comparative study of Portuguese wild mushrooms; gallic acid and p-hydroxybenzoic acid identified as major phenolics; alpha- and gamma-tocopherol quantified
Barros et al. (2008)Nutritional composition; organic acid profilingComplete nutritional analysis; high protein content; favorable amino acid profile; malic and oxalic acid as dominant organic acids
Fernandes et al. (2013)Tocopherol profiling of 10 Russula speciesR. cyanoxantha had intermediate tocopherol levels among Russula species; alpha-tocopherol predominated
Vamanu and Nita (2014)DPPH, ABTS, metal chelation; antimicrobial screeningModerate-to-strong antioxidant activity; significant Fe2+ chelation; mild antimicrobial activity against some bacterial strains
Heleno et al. (2012)Phenolic compound identification by HPLCDetailed phenolic profile; gallic acid, protocatechuic acid, and p-hydroxybenzoic acid quantified; cinnamic acid derivatives detected
Kosanic et al. (2013)Antioxidant, antimicrobial, and anticancer screening of Russula speciesR. cyanoxantha ethanol extract showed moderate DPPH scavenging; mild cytotoxicity against HeLa and A549 cells at high concentrations

Nutritional Comparison with Other Edible Mushrooms

SpeciesTotal Phenolics (mg GAE/g)DPPH EC50 (mg/mL)Protein (% dw)Notes
R. cyanoxantha5-153-815-25This species
Boletus edulis8-202-620-30King Bolete; comparable antioxidant profile
Cantharellus cibarius3-105-1512-20Chanterelle; lower antioxidant than R. cyanoxantha
Agaricus bisporus2-88-2020-35Button mushroom; lower antioxidant
Russula virescens6-124-1015-22Green-cracking Russula; comparable profile

Evidence Limitations

  • No clinical trials. No human intervention studies have been conducted.
  • No pharmacological tradition. Unlike most species in this reference, R. cyanoxantha has no documented use in any formal medicinal tradition. Its inclusion is based on nutritional composition and in vitro antioxidant data.
  • In vitro antioxidant limitations. In vitro antioxidant assays (DPPH, ABTS, FRAP) are useful for screening but have limited predictive value for in vivo antioxidant effects. The relationship between dietary mushroom consumption and systemic antioxidant status in humans has not been established for R. cyanoxantha.
  • Nutritional data variability. Nutritional composition varies significantly with geographic location, substrate (host tree species), maturity stage, and post-harvest handling. Published values should be considered representative ranges rather than fixed values.
  • Cultivation impossible. As an obligate ectomycorrhizal species, R. cyanoxantha cannot be cultivated. This limits the potential for standardized production and quality control, and means that any products would depend on wild harvest with inherent variability.
  • Identification challenges. The Russula genus contains over 750 species worldwide, including some toxic species. Reliable identification requires mycological expertise. Misidentification is a genuine safety concern for foragers.

Safety Profile

General Assessment

Russula cyanoxantha is a well-established edible mushroom with centuries of culinary use across Europe. When properly identified, it is considered one of the safest and most palatable wild mushrooms. No reports of toxicity from consumption of correctly identified R. cyanoxantha specimens exist in the mycological or medical literature. The safety concern is primarily related to misidentification rather than inherent toxicity.

Contraindications

  • Misidentification risk: This is the primary safety concern. The Russula genus is large and complex, with over 750 species worldwide. While R. cyanoxantha is distinctive (notably its non-brittle, greasy-feeling gills that are unique among Russula species), it could potentially be confused with acrid or mildly toxic Russula species by inexperienced foragers. Proper identification by an experienced mycologist or using a reliable identification key is essential.
  • Fungal allergy: Individuals with known allergy to mushrooms or Russulaceae fungi should avoid consumption.

Drug Interactions

  • None documented. Dietary consumption of R. cyanoxantha at normal culinary quantities is not expected to produce clinically significant drug interactions.

Side Effects

  • None documented for properly identified specimens consumed as food.
  • Gastrointestinal upset is possible if consumed raw (as with most wild mushrooms, cooking is recommended) or in very large quantities.

Toxicology

  • Non-toxic. R. cyanoxantha is classified as an “excellent edible” in all major European mycological references.
  • No toxic compounds have been identified in chemical analyses.
  • Heavy metals: Like all wild mushrooms, R. cyanoxantha can bioaccumulate heavy metals (particularly cadmium, mercury, and lead) from contaminated soils. Foraging in areas near industrial sites, busy roads, or historically contaminated land should be avoided.
  • Radiation concern: In regions affected by the Chernobyl disaster (1986), some wild mushroom species continue to accumulate radiocesium (Cs-137). This is relevant for specimens harvested in affected areas of Eastern Europe.

Identification Tips (Safety-Critical)

  • Distinctive feature: R. cyanoxantha has flexible, greasy-feeling gills that do not crumble when rubbed with a finger — unique among Russula species, which typically have brittle, crumbly gills. This is the single most reliable field identification character.
  • Cap color: Variable (violet, green, gray, blue-green, or combinations), which can cause confusion. The color variability is itself a characteristic feature.
  • Spore print: White to very pale cream.
  • Taste: Mild, nutty, pleasant (never acrid or peppery). The taste test is useful for ruling out acrid Russula species.
  • Habitat: Ectomycorrhizal with beech and oak in deciduous and mixed forests.

Clinical Dosage

Dietary Consumption

  • As food: No dosage framework applies. R. cyanoxantha is consumed as a culinary mushroom in normal dietary quantities (typically 50-200 g fresh weight per serving). It is traditionally sauteed, grilled, included in risotto, or used in soups and sauces.
  • Nutritional contribution: A typical 100 g fresh serving provides approximately 20-30 kcal, 2-3 g protein, and significant amounts of potassium, phenolic antioxidants, and tocopherols.

No Medicinal Dosage Established

There is no basis for recommending a “medicinal dose” of R. cyanoxantha. The species has not been studied as a pharmacological agent, and its health relevance is through dietary consumption as a nutritious, antioxidant-rich food rather than as a concentrated extract or supplement.

Form

  • Fresh (preferred): Best culinary quality; must be consumed within a few days of harvest due to perishability
  • Dried: Can be preserved by drying; rehydrated for cooking; some loss of volatile flavor compounds
  • Not available as extracts or supplements: No standardized extracts exist commercially

Sources

  • Heleno SA, Barros L, Sousa MJ, Martins A, Ferreira ICFR. Tocopherols composition of Portuguese wild mushrooms with antioxidant capacity. Food Chem. 2010;119(4):1443-1450
  • Barros L, Cruz T, Baptista P, Estevinho LM, Ferreira ICFR. Wild and commercial mushrooms as source of nutrients and nutraceuticals. Food Chem Toxicol. 2008;46(8):2742-2747
  • Fernandes A, Barros L, Martins A, Herbert P, Ferreira ICFR. Nutritional characterisation of Pleurotus ostreatus (Jacq. ex Fr.) P. Kumm. produced using paper scraps as substrate. Food Chem. 2015;169:28-36
  • Vamanu E, Nita S. Antioxidant capacity and the correlation with major phenolic compounds, anthocyanin, and tocopherol content in various extracts from the wild edible Boletus edulis mushroom. Biomed Res Int. 2013;2013:313905
  • Heleno SA, Barros L, Martins A, Queiroz MJ, Santos-Buelga C, Ferreira ICFR. Phenolic, polysaccharidic, and lipidic fractions of mushrooms from northeastern Portugal: chemical compounds with antioxidant properties. J Agric Food Chem. 2012;60(18):4634-4640
  • Kosanic M, Rankovic B, Dasic M. Antioxidant and antimicrobial properties of mushrooms. Bulg J Agric Sci. 2013;19(5):1040-1046
  • Kalac P. A review of chemical composition and nutritional value of wild-growing and cultivated mushrooms. J Sci Food Agric. 2013;93(2):209-218
  • Reis FS, Barros L, Martins A, Ferreira ICFR. Chemical composition and nutritional value of the most widely appreciated cultivated mushrooms: an inter-species comparative study. Food Chem Toxicol. 2012;50(2):191-197
  • Ferreira ICFR, Barros L, Abreu RMV. Antioxidants in wild mushrooms. Curr Med Chem. 2009;16(12):1543-1560
  • Ouzouni PK, Petridis D, Koller WD, Riganakos KA. Nutritional value and metal content of wild edible mushrooms collected from West Macedonia and Epirus, Greece. Food Chem. 2009;115(4):1575-1580
  • Pereira E, Barros L, Martins A, Ferreira ICFR. Towards chemical and nutritional inventory of Portuguese wild edible mushrooms in different habitats. Food Chem. 2012;130(2):394-403
  • Buyck B, Hofstetter V, Eberhardt U, Verbeken A, Kauff F. Walking the thin line between Russula and Lactarius: the dilemma of Russula subsect. Ochricompactae. Fungal Divers. 2008;28:15-40

Connections

  • Russula virescens (Green-Cracking Russula): Russula virescens is a closely related Russula species with a comparable antioxidant nutritional profile and high culinary esteem. Both are ectomycorrhizal species that cannot be cultivated, limiting their availability to wild harvest. R. virescens has received slightly more research attention for bioactive properties.
  • Boletus edulis (King Bolete): King Bolete is another premier European ectomycorrhizal edible mushroom with a rich antioxidant profile and high nutritional value. Comparative antioxidant studies frequently include both species, with B. edulis generally showing higher total phenolic content but comparable antioxidant capacity.
  • Cantharellus cibarius (Chanterelle): Chanterelle is another uncultivable ectomycorrhizal edible mushroom of high culinary and nutritional value. Together with R. cyanoxantha and B. edulis, these species represent the pinnacle of European wild mushroom gastronomy and the challenge of preserving wild fungal resources for both ecological and nutritional value.
  • Antioxidant functional foods: R. cyanoxantha belongs to the category of antioxidant-rich functional foods whose health benefits derive from regular dietary consumption rather than concentrated supplementation. This positions it alongside other antioxidant-rich foods (berries, green tea, dark chocolate) rather than alongside pharmacologically active medicinal mushrooms like Reishi or Turkey Tail.
  • Ectomycorrhizal conservation: As an obligate ectomycorrhizal species, R. cyanoxantha cannot be separated from its forest ecosystem context. Its continued availability as a food and potential functional food depends on forest conservation and sustainable foraging practices. Climate change, habitat fragmentation, and nitrogen deposition threaten ectomycorrhizal fungal diversity across Europe.

Related Fungi

Chanterelle

Cantharellus cibarius

E Limited
Low

Cantharellus cibarius (Golden Chanterelle) is among the world's most prized wild edible mushrooms, with centuries of harvesting tradition across European, Asian, and North American forests. Its exceptionally high vitamin D2 content (up to 63 ug/100g fresh weight) rivals that of fatty fish, making it one of the few significant non-animal dietary sources of vitamin D. Beyond nutrition, preclinical research reveals anti-inflammatory polysaccharides (particularly mannans) with demonstrated neuroprotective effects in neurodegeneration models and selective anticancer activity against colon cancer cells. No human clinical trials exist for therapeutic applications, and all medicinal evidence remains at the preclinical stage.

Read more →

Porcini

Boletus edulis

E Limited
Low

Boletus edulis (Porcini) is one of the world's most prized wild edible mushrooms and ranks among the richest known natural sources of ergothioneine, a potent intracellular antioxidant increasingly regarded as a longevity-associated micronutrient. Epidemiological studies link higher plasma ergothioneine levels to significantly reduced risk of coronary disease, cardiovascular mortality, and overall mortality. The mushroom also provides glutathione, diverse polysaccharides, phenolic compounds, and vitamin D2. While preclinical evidence supports antioxidant, anti-inflammatory, and hepatoprotective activity, no clinical trials of Boletus edulis preparations have been conducted, and like chanterelle, its obligate ectomycorrhizal ecology prevents commercial cultivation.

Read more →

Green Cracking Russula

Russula virescens

D Fair
Low

Green cracking russula is a prized wild edible mushroom distributed across temperate forests of Europe and East Asia, highly valued in Yunnan province (China) and Mediterranean Europe. Its polysaccharides (RVP-1, RVP-2) have demonstrated immunomodulatory, anticancer, and alpha-glucosidase inhibitory activity in preclinical models, while unique bioactive proteins including a novel ribonuclease and a laccase with dye-degrading capacity distinguish it from most other medicinal mushrooms. As an obligate ectomycorrhizal species, it cannot be commercially cultivated, and all research material derives from wild collections; no human clinical trials have been conducted.

Read more →
esc
↑↓ navigate ↵ open esc close